| Makinzie Oden, PHARMD | |
|
1200 E Pecan St, Altus, OK 73521-6192 | |
| (580) 379-5700 | |
| Not Available |
| Full Name | Makinzie Oden |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1200 E Pecan St, Altus, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104271808 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 14741 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Makinzie Oden, PHARMD 20413 E County Road 159, Altus, OK 73521-8318 Ph: (580) 370-6862 | Makinzie Oden, PHARMD 1200 E Pecan St, Altus, OK 73521-6192 Ph: (580) 379-5700 |
News Archive
Coincident with the widespread adoption of PSA screening, the proportion of American men diagnosed with organ-confined, low risk prostate cancer has increased significantly during the last two decades. In a study scheduled for publication in the February 2009 issue of The Journal of Urology, researchers report that for low-income men, the opposite is true, with more men undiagnosed until their cancers had reached more advanced stages.
Due to the complicated nature of preparing injections, mistakes are made in around a third of doses. Although these are often minor errors, it is a statistic that University of Bath pharmacist Dr Matthew Jones wants to change with a new project to improve patient safety.
Samsung Medical Center and the world's leading bio-pharmaceutical company Pfizer Inc. announced that they have formed a research partnership to jointly analyze tumors from Korean patients to generate gene expression profiles and that may ultimately direct therapies and enhance clinical outcomes in the patients with liver cancer.
"Our study shows that poor mental health in children and teenagers has a large impact on the length of time they will stay in school," says Dr. Lehrer. He notes a large number of school-based programs have recently been introduced to prevent childhood obesity through lifestyle changes, but suggests the net should be cast more widely. "It's important for policymakers to target health conditions that are not the easiest to identify - like inattention - but may have larger impacts on one's future."
Repligen Corporation announced today that it has filed an Investigational New Drug Application (IND) with the Food and Drug Administration (FDA) for a Phase 1 study of RG2833, a selective histone deacetylase 3 (HDAC-3) inhibitor. This is a double-blind, single ascending dose, Phase 1 study in healthy volunteers to evaluate the pharmacokinetic and safety profile of RG2833 in up to 40 subjects.
› Verified 7 days ago
Dr. Ian Cirasunda Dettman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 N 1st St Bldg 46, Altus, OK 73523 Phone: 580-481-5224 | |
Elizabeth Myers, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2101 N Main St, Altus, OK 73521 Phone: 580-477-0381 Fax: 580-477-1749 | |
Mr. David Eugene Pickett, D.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 205 S Park Ln Ste 110, Altus, OK 73521 Phone: 580-482-6464 | |
Mr. Lonnie D Long, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 N Main St, Altus, OK 73521 Phone: 580-477-0381 Fax: 580-477-1749 | |
Jennifer J Earls, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1132 N Main St, Altus, OK 73521 Phone: 580-477-1316 Fax: 580-477-2154 | |
Logan Hunter Price, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2500 N Main St, Altus, OK 73521 Phone: 580-482-8466 |